Olink Holding AB

General Information

Our purpose is to enable and accelerate the field of proteomics by providing a platform of products and services, developed with key opinion leaders (KOLs), that are deployed across major biopharmaceutical companies and leading clinical and academic institutions, to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. Since our inception, we have served a customer base of approximately 630 customer accounts in over 40 countries worldwide. We support 30 of the world’s largest 40 biopharmaceutical companies by 2019 revenue, including all of the largest 19, and many leading academic institutions.

Employees: 214
Founded: 2018
Contact Information
Address Uppsala Science Park, SE-751 83, Uppsala, Sweden
Phone Number +46 (0) 18 - 444 39 70
Web Address http://www.olink.com
View Prospectus: Olink Holding AB
Financial Information
Market Cap $2023mil
Revenues $54.1 mil (last 12 months)
Net Income $-6.8 mil (last 12 months)
IPO Profile
Symbol OLK
Exchange NASDAQ
Shares (millions): 17.7
Price range $20.00 - $20.00
Est. $ Volume $352.9 mil
Manager / Joint Managers Goldman Sachs/ Morgan Stanley/ SVB Leerink
CO-Managers BTIG
Expected To Trade: 3/25/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change